Structure Therapeutics has dropped over 55% as its GLP-1 pill targets obesity, yet analysts remain bullish with high price ...

BlackRock is evolving from a traditional asset manager into a broader platform spanning technology, private markets, and ...

SCHD offers higher income and diversification but faces growth limits, while VIG favors total return and dividend growth.

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Gator Capital Management reports strong Q2 gains and sees upside in WEX Inc. amid activist pressure and rate outlook. Read ...

IBHF offers a near-7% yield after expenses, with a portfolio mainly in BB and B-rated bonds. Click here to read more about ...

EXI offers global exposure and less concentration risk than XLI but underperformed. Check out the analysis of the industrial ...

Atai Capital Management reflects on its Cable One investment misfire, highlighting how debt and declining earnings can ...

Superior Group of Companies continues to grow, but the rest of this year will likely be more mixed. Read why maintaining SGC ...

Serve Robotics is rapidly expanding its robot fleet and delivery volumes, targeting 2,000 robots by the end of 2025. Read why ...

SPHQ overweights mature sectors like industrials and consumer staples while underweighting big tech vs. S&P 500. Read more on ...

FRA's distributions exceed earnings, raising the likelihood of a dividend cut to preserve NAV health. Read why I am on the ...